Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 111

1.

[Usefulness of copeptin in the diagnosis of acute coronary syndrome in the emergency department of a tertiary hospital].

Calmarza P, Lapresta C, García-Castañón S, López-Perales C, Pérez-Guerrero A, Portolés A.

Clin Investig Arterioscler. 2016 Sep - Oct;28(5):209-215. doi: 10.1016/j.arteri.2016.07.001. Spanish.

PMID:
27650658
2.

Adverse drug reactions in neonates: a prospective study.

Belén Rivas A, Arruza L, Pacheco E, Portoles A, Diz J, Vargas E.

Arch Dis Child. 2016 Apr;101(4):371-6. doi: 10.1136/archdischild-2015-309396.

PMID:
26819267
3.

Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.

Zuidmeer-Jongejan L, Huber H, Swoboda I, Rigby N, Versteeg SA, Jensen BM, Quaak S, Akkerdaas JH, Blom L, Asturias J, Bindslev-Jensen C, Bernardi ML, Clausen M, Ferrara R, Hauer M, Heyse J, Kopp S, Kowalski ML, Lewandowska-Polak A, Linhart B, Maderegger B, Maillere B, Mari A, Martinez A, Mills EN, Neubauer A, Nicoletti C, Papadopoulos NG, Portoles A, Ranta-Panula V, Santos-Magadan S, Schnoor HJ, Sigurdardottir ST, Stahl-Skov P, Stavroulakis G, Stegfellner G, Vázquez-Cortés S, Witten M, Stolz F, Poulsen LK, Fernandez-Rivas M, Valenta R, van Ree R.

Int Arch Allergy Immunol. 2015;166(1):41-51. doi: 10.1159/000371657.

4.

FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies.

Zuidmeer-Jongejan L, Fernandez-Rivas M, Poulsen LK, Neubauer A, Asturias J, Blom L, Boye J, Bindslev-Jensen C, Clausen M, Ferrara R, Garosi P, Huber H, Jensen BM, Koppelman S, Kowalski ML, Lewandowska-Polak A, Linhart B, Maillere B, Mari A, Martinez A, Mills CE, Nicoletti C, Opstelten DJ, Papadopoulos NG, Portoles A, Rigby N, Scala E, Schnoor HJ, Sigurdardottir ST, Stavroulakis G, Stolz F, Swoboda I, Valenta R, van den Hout R, Versteeg SA, Witten M, van Ree R.

Clin Transl Allergy. 2012 Mar 9;2(1):5. doi: 10.1186/2045-7022-2-5.

5.

Risk of cerebrovascular accident associated with use of antipsychotics: population-based case-control study.

Laredo L, Vargas E, Blasco AJ, Aguilar MD, Moreno A, Portolés A.

J Am Geriatr Soc. 2011 Jul;59(7):1182-7. doi: 10.1111/j.1532-5415.2011.03479.x.

PMID:
21718267
6.

Truncated area under the urinary excretion rate curve in the evaluation of alendronate bioequivalence after a single dose in healthy volunteers.

Portolés A, Prieto E, Calvo A, Laredo L, Fernández N, Vargas E.

Arzneimittelforschung. 2009;59(8):397-402. doi: 10.1055/s-0031-1296414.

PMID:
19813462
7.

[Pilot Drug Utilization Study of systemic antifungal agents in the Hospital Clínico San Carlos. Proposal of a study method].

Alonso S, Arribi A, Vergas J, Martín MC, Arce B, Terleira A, Portolés A.

Rev Esp Quimioter. 2009 Sep;22(3):127-34. Spanish.

8.

A clinical distortion index for compressed echocardiogram evaluation: recommendations for Xvid codec.

Alesanco A, Hernández C, Portolés A, Ramos L, Aured C, García M, Serrano P, García J.

Physiol Meas. 2009 May;30(5):429-40. doi: 10.1088/0967-3334/30/5/001.

PMID:
19349650
9.

Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale.

Montejo AL, Prieto N, Terleira A, Matias J, Alonso S, Paniagua G, Naval S, Parra DG, Gabriel C, Mocaër E, Portolés A.

J Psychopharmacol. 2010 Jan;24(1):111-20. doi: 10.1177/0269881108096507.

PMID:
18801825
10.

Clinical Quality Guarantee in Real-time ECG Compression.

Alesanco A, García J, Serrano P, Ramos L, Portolés A, Istepanian R.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:39-42.

PMID:
18001883
11.

[The importance of investigating the internal thoracic artery before coronary artery surgery in Leriche's syndrome].

Ferrer MC, Calvo I, Sánchez-Rubio J, Galache G, Diarte JA, Lukic A, Portolés A, Placer L.

Rev Esp Cardiol. 2007 Nov;60(11):1198-201. Spanish.

12.

Effect of drug-test interactions on length of hospital stay.

Terleira A, Portolés A, Rojas A, Vargas E.

Pharmacoepidemiol Drug Saf. 2007 Jan;16(1):39-45.

PMID:
17013947
13.

Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.

Portolés A, Calvo A, Terleira A, Laredo L, Resplandy G, Gorostiaga C, Moreno A.

J Clin Pharmacol. 2006 Oct;46(10):1195-203.

PMID:
16988209
14.

Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers: an open-label, pharmacokinetic interaction clinical trial.

Portolés A, Terleira A, Calvo A, Martínez I, Resplandy G.

J Clin Pharmacol. 2006 Oct;46(10):1188-94.

PMID:
16988208
15.

Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.

Portolés A, Palau E, Puerro M, Vargas E, Picazo JJ.

Rev Esp Quimioter. 2006 Mar;19(1):65-75.

16.

Bioequivalence study of two different tablet formulations of carvedilol in healthy volunteers.

Portolés A, Filipe A, Almeida S, Terleira A, Vallée F, Vargas E.

Arzneimittelforschung. 2005;55(4):212-7.

PMID:
15901044
17.
18.

Truncated AUC in the evaluation of fluconazole bioequivalence. A cross-over, randomised, open-label study in healthy volunteers.

Portolés A, Almeida S, Terleira A, de Pablo I, Filipe A, Cruz Caturla M, Moreno A.

Arzneimittelforschung. 2004;54(11):752-6.

PMID:
15612616
19.

Bioequivalence study of two formulations of enalapril, at a single oral dose of 20 mg (tablets): A randomized, two-way, open-label, crossover study in healthy volunteers.

Portolés A, Terleira A, Almeida S, García-Arenillas M, Caturla MC, Filipe A, Vargas E.

Curr Ther Res Clin Exp. 2004 Jan;65(1):34-46. doi: 10.1016/S0011-393X(04)90003-3.

20.

A new high-absorption-rate Paracetamol 500-mg formulation: a comparative bioavailability study in healthy volunteers.

Portolés A, Puerro M, Terleira A, Rodríguez A, Caturla MC, Fernández N, Vargas E.

Curr Ther Res Clin Exp. 2003 Jul;64(7):401-11. doi: 10.1016/S0011-393X(03)00110-3.

Items per page

Supplemental Content

Loading ...
Support Center